跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 84 条关于
“Livzon MABPharm”
全部
84
临床试验
15
药物
41
机构
16
资讯
12
3个月前
Livzon's IL-17 Inhibitor Lecankitug Nears Second Indication as NMPA Accepts Ankylosing Spondylitis Application
4个月前
Livzon Pharmaceutical Receives Regulatory Approval for Brexpiprazole Microsphere Clinical Trial in Adult Schizophrenia
去年
Livzon's Dual-Target IL-17A/F Antibody LZM012 Outperforms Secukinumab in Phase III Psoriasis Trial
去年
Onconic's Jaqbo Shows 100% Efficacy in Phase 3 Gastric Ulcer Trial, Seeks Indication Expansion
去年
Jeil Pharm Launches Jaqbo, a Novel P-CAB for Peptic Ulcer Treatment in Korea
去年
Brii Biosciences Licenses Novel Antibiotic BRII-693 to Joincare Group for Greater China Market
3个月前
Onconic Therapeutics Advances Global Expansion of GERD Drug Jakubo with Mexico NDA Filing and U.S. Manufacturing Partnership
2个月前
Vietnam's Pharma Market Set to Top $10 Billion by 2026 Amid Regulatory Reforms and Demographic Shifts
去年
Vivozon's Non-Narcotic Pain Reliever 'Unafra' Set to Launch in 2025
去年
Novel LION Trial Combines Anti-inflammatory Drug with Immunotherapy to Combat Advanced Cancers
第 1 页,共 2 页
上一页
下一页